Testing the ETM: Examination and Comparison of Different Methods

Description

This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.

Conditions

Cigarette Smoking

Study Overview

Study Details

Study overview

This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.

Testing the Experimental Tobacco Marketplace: Examination and Comparison of Different Methods

Testing the ETM: Examination and Comparison of Different Methods

Condition
Cigarette Smoking
Intervention / Treatment

-

Contacts and Locations

Roanoke

Fralin Biomedical Research Institute, Roanoke, Virginia, United States, 24016

Roanoke

Fralin Biomedical Research Institute, Roanoke, Virginia, United States, 24016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provide informed consent
  • * Be at least 21 years of age or older
  • * Stable tobacco use patterns for at least three months
  • * Smoke at least 5 cigarettes daily
  • * Use other tobacco products less than weekly
  • * Have access to a computer and internet
  • * report uncontrolled physical or mental health conditions (e.g., uncontrolled diabetes, high blood pressure, major depressive disorder, etc.),
  • * use of smoking cessation medications (e.g., nicotine replacement, bupropion, varenicline) in the past 30 days,
  • * report concrete, immediate plans to alter/quit using their usual tobacco products in the next 30 days,
  • * be pregnant or lactating

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Virginia Polytechnic Institute and State University,

Roberta Freitas-Lemos, Ph.D., PRINCIPAL_INVESTIGATOR, Fralin Biomedical Research Institute at VTC

Study Record Dates

2025-11-14